How can we explain the sudden decline in adoption of Signant Health's eConsent module among new clinical trial sponsors this year?

Introduction

The sudden decline in adoption of Signant Health's eConsent module among new clinical trial sponsors this year is a critical issue that requires immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and address the root cause while considering both short-term and long-term implications for our product strategy.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a specific event or change that triggered this decline. Has there been any significant product update or market event in the past 3-6 months?

Why it matters: Identifying a specific trigger point can help narrow down potential causes. Expected answer: A major product update or market event occurred recently. Impact on approach: If confirmed, we'd focus on changes around that time period.

• Considering user segments, I'm curious about the profile of new sponsors who aren't adopting. Are we seeing this decline across all types of sponsors, or is it more pronounced in certain segments (e.g., small biotech vs. large pharma)?

Why it matters: Understanding affected segments can reveal specific pain points or needs. Expected answer: The decline is more significant in certain sponsor segments. Impact on approach: We'd tailor our investigation and solutions to the most affected segments.

• Thinking about competitive landscape, have there been any notable changes in competitor offerings or pricing structures recently?

Why it matters: External factors could be influencing sponsor decisions. Expected answer: Some competitors have introduced new features or pricing models. Impact on approach: We'd need to assess our competitive positioning and value proposition.

• Regarding adoption metrics, I'm wondering about the specific definition of "adoption" in this context. Are we measuring initial sign-ups, active usage, or something else?

Why it matters: Clarifying the metric ensures we're addressing the right problem. Expected answer: Adoption is defined as active usage within the first 30 days after sign-up. Impact on approach: We'd focus on factors affecting early-stage usage rather than just sign-ups.